This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Charting a New Course in Migraine Management

Charting a New Course in Migraine Management



Time to Complete

1 hour


December 26, 2019


December 26, 2020
Add to Queue

Maximum Credits

1.00 / AMA PRA Category 1 CreditsTM

Accredited Provider

Jointly provided by Postgraduate Institute for Medicine and Miller Medical Communications, LLC.

Commercial Supporter

This activity is supported by an independent educational grant provided by Lilly.

Program Description

Migraine is 3 times more common in women than in men, and nearly 40% of all women experience migraine during their reproductive life cycle. Obstetricians and gynecologists are uniquely positioned not only to make a diagnosis and work with a patient to determine a treatment plan and lessen migraine-related disability, but also to be the reliable source of guidance for those patients who increasingly seek information and clinical care as their awareness of new treatment options for migraine increases.

Using case examples, this activity focuses on the role of hormones in migraine, fundamentals of migraine pathophysiology, diagnosis, a review of currently available therapies for migraine preventions and treatment, and practical considerations for therapy selection.

Intended Audience

This activity is intended for health care professionals engaged in the care of patients with migraine.

Educational Objectives

  • Identify gaps in the quality of care provided to patients with migraine, the impact on patient quality of life, and opportunities to improve outcomes
  • Summarize the efficacy, adverse effects, and adherence challenges of older or nonspecifically targeted migraine therapies
  • Using efficacy and tolerability data from clinical trials, choose new migraine-specific, selectively targeted therapies for migraine prevention and treatment for appropriate patients

Conflicts of Interest Disclosure Policy

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.


Wendy L. Wolfman, MD, FRCS(C),FACOG, NCMP (Program Chair)
Department of Obstetrics and Gynaecology
University of Toronto
Menopause and Premature Ovarian Insufficiency Clinic
Mount Sinai Hospital

Toronto, Ontario, Canada

Dr Wolfman has nothing to disclose.

Jan Lewis Brandes, MD, MS, FAAN, FAHS
Assistant Clinical Professor
Department of Neurology
Vanderbilt University School of Medicine
Director and Founder
Nashville Neuroscience Group
Nashville, Tennessee

Dr. Brandes discloses the following:
Consulting fees: Alder, Amgen, Avanir/Valeant, Depomed, Lilly, Promius, Supernus, Teva Pharmaceuticals
Contracted research: Alder, Allergan, Amgen, Arteus, Biohaven, Colucid, Lilly, Teva Pharmaceuticals, Zosano

Planners and Managers

The PIM planners and managers have nothing to disclose.

The Miller Medical Communications, LLC, planners and managers have nothing to disclose.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Miller Medical Communications, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.




There are no fees for participating and receiving CME/CE credit for this activity. During the period December 28, 2019 through December 28, 2020, participants must read the learning objectives and faculty disclosures and study the educational activity.

If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation. Upon successfully completing the post-test with a score of 66% or better and the activity evaluation, your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact Postgraduate Institute for Medicine at: or (303) 799-1930.

Privacy Policy

Postgraduate Institute for Medicine Privacy Policy

Miller Medical Communications, LLC- Kat Golden,, 212-661-7400, ext. 8

myCME privacy policy

System Requirements

CME University requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue